Ketamine Shows No Sustained Hemodynamic Advantage Over Propofol During Intubation

Tracheal intubation in the intensive care unit is a high-risk procedure frequently complicated by significant hemodynamic perturbations [1]. Clinicians often prioritize agents like etomidate or ketamine for their perceived cardiovascular stability, yet concerns persist regarding etomidate-induced adrenal suppression and its potential impact on mortality [2, 3]. Rapid sequence intubation in emergency settings requires careful sedative selection to mitigate the risk of post-intubation hypotension, a complication linked to increased morbidity and mortality [4]. While patient-important outcomes such as long-term survival and quality of life are the ultimate goals of critical care, many trials remain focused on immediate physiological parameters [5]. A recent randomized controlled trial now provides data on how the choice between two common induction agents, ketamine and propofol, affects early blood pressure management and downstream outcomes in critically ill adults.